Literature DB >> 12790601

Synthesis of enantiopure 3-azabicyclo[3.2.0]heptanes by diastereoselective intramolecular [2+2] photocycloaddition reactions on chiral perhydro-1,3-benzoxazines.

Rafael Pedrosa1, Celia Andrés, Javier Nieto, Soledad del Pozo.   

Abstract

[2+2] photocycloadditions involving chiral 3-acryloyl-2-vinylperhydro-1,3-benzoxazines derived from (-)-8-aminomenthol are highly diastereoselective reactions. The facial selectivity depends on the type of substitution at the vinyl double bond, and always leads to cis-fused bicyclic derivatives. The de is good for compounds with one substituent at the outer carbon of the double bond at C-2, but only one diastereomer is formed in cyclizations of compounds with two substituents at that position. The elimination of the menthol appendage gives enantiopure 3-azabicyclo[3.2.0]heptanes.

Entities:  

Year:  2003        PMID: 12790601     DOI: 10.1021/jo034251c

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  Recent Advances in the Synthesis of Cyclobutanes by Olefin [2 + 2] Photocycloaddition Reactions.

Authors:  Saner Poplata; Andreas Tröster; You-Quan Zou; Thorsten Bach
Journal:  Chem Rev       Date:  2016-03-28       Impact factor: 60.622

2.  Stereoselective Synthesis and Investigation of Isopulegol-Based Chiral Ligands.

Authors:  Tam Minh Le; Tamás Szilasi; Bettina Volford; András Szekeres; Ferenc Fülöp; Zsolt Szakonyi
Journal:  Int J Mol Sci       Date:  2019-08-19       Impact factor: 5.923

3.  Stereoselective synthesis and application of isopulegol-based bi- and trifunctional chiral compounds.

Authors:  Tam Minh Le; Thu Huynh; Gábor Endre; András Szekeres; Ferenc Fülöp; Zsolt Szakonyi
Journal:  RSC Adv       Date:  2020-10-19       Impact factor: 4.036

4.  Stereoselective Synthesis and Antiproliferative Activity of Steviol-Based Diterpen Aminodiols.

Authors:  Dániel Ozsvár; Viktória Nagy; István Zupkó; Zsolt Szakonyi
Journal:  Int J Mol Sci       Date:  2019-12-26       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.